Clinical Trials Directory

Trials / Conditions / Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation

3 registered clinical trials studyying Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation.

StatusTrialSponsorPhase
CompletedA Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) W
NCT04691648
Astellas Pharma Korea, Inc.—
CompletedA Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory
NCT03730012
Astellas Pharma Global Development, Inc.Phase 1 / Phase 2
CompletedA Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Tre
NCT02752035
Astellas Pharma Global Development, Inc.Phase 3